Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Quantities of Clostridium botulinum organisms and toxin in feces and presence of Clostridium botulinum toxin in the serum of an infant with botulism

View through CrossRef
A 7-week-old boy presented with symptoms and signs characteristic of infant botulism, and the diagnosis was confirmed by the detection of Clostridium botulinum type A organisms and toxin in the feces. The levels of organisms and toxin in the feces were measured throughout the 81-day period in hospital. The maximum levels detected were 2.46 x 10(8) C. botulinum type A colony-forming units and 64,000 mouse 100% lethal doses of type A toxin per g (wet weight) of feces. C. botulinum toxin was also detected in two samples of the patient's serum, collected 3 and 10 days after admission. Improvement in the patient's clinical condition occurred before the levels of organisms and toxin in the feces reached their maxima. A slight improvement may also have occurred while toxin was still present in the serum.
Title: Quantities of Clostridium botulinum organisms and toxin in feces and presence of Clostridium botulinum toxin in the serum of an infant with botulism
Description:
A 7-week-old boy presented with symptoms and signs characteristic of infant botulism, and the diagnosis was confirmed by the detection of Clostridium botulinum type A organisms and toxin in the feces.
The levels of organisms and toxin in the feces were measured throughout the 81-day period in hospital.
The maximum levels detected were 2.
46 x 10(8) C.
botulinum type A colony-forming units and 64,000 mouse 100% lethal doses of type A toxin per g (wet weight) of feces.
C.
botulinum toxin was also detected in two samples of the patient's serum, collected 3 and 10 days after admission.
Improvement in the patient's clinical condition occurred before the levels of organisms and toxin in the feces reached their maxima.
A slight improvement may also have occurred while toxin was still present in the serum.

Related Results

Outbreak of type A foodborne botulism
Outbreak of type A foodborne botulism
The purpose — to study the clinical and epidemiological features of the outbreak of type A foodborne botulism in Kazan. Material and methods. We analyzed 22 case histories of pati...
Role of botulinum toxin in hand and upper limb disorders relevant to hand therapy
Role of botulinum toxin in hand and upper limb disorders relevant to hand therapy
Introduction This article reviews the mechanism of action of botulinum toxin and provides an overview of its use in hand disorders relevant to hand therapy such as hyperhidrosis, s...
Inhibition of Clostridium (C.) botulinum and its toxins by probiotic bacteria and their metabolites: An update review
Inhibition of Clostridium (C.) botulinum and its toxins by probiotic bacteria and their metabolites: An update review
Clostridium (C.) botulinum is the causative agent of foodborne poisoning such as botulism, which includes high mortality rates in animals and humans. Probiotic bacteria play critic...
Construction of Recombinant Protein of Botulinum Neurotoxin Light Chain and Analysis of Cleavage Effect on VAMP1 Protein in Brown Rat
Construction of Recombinant Protein of Botulinum Neurotoxin Light Chain and Analysis of Cleavage Effect on VAMP1 Protein in Brown Rat
In order to explore the feasibility of the new rodenticide of type D Botulinum toxin to prevent and control the population density of pests in farmland from a molecular perspective...
Iatrogenic botulism after botulinum toxin type A: Five cases
Iatrogenic botulism after botulinum toxin type A: Five cases
Botulinum toxin A (BTX-A) is frequently used for spasticity, focal dystonia, hemifacial spasm, hyperhidrosis, strabismus, chronic migraine and cosmetic purposes. Therapeutic use is...
Outcome of delayed versus immediate casting on spasticity of lower limb muscles in cerebral palsy post-botulinum toxin injection
Outcome of delayed versus immediate casting on spasticity of lower limb muscles in cerebral palsy post-botulinum toxin injection
Background: Botulinum toxin type A (BTX-A) is widely used to treat spasticity in children. The optimal strategy for the combined treatment of casting and BTX-A injections is not kn...
Facing depression with botulinum toxin: Literature review
Facing depression with botulinum toxin: Literature review
IntroductionAffecting over 120 million people, major depressive disorder (MDD) is characterized by low mood, lack of interest and a cluster of other vegetative and cognitive sympto...
Botulinum Neurotoxins
Botulinum Neurotoxins
AbstractBotulinum neurotoxins (BoNTs) are Janus‐faced biological agents. They are the most poisonous substances known and the causative agents of botulism, a deadly neuroparalytic ...

Back to Top